Fractional exhaled nitric oxide and the peripheral blood eosinophil count as biomarkers of the response to mepolizumab in patients with severe eosinophilic asthma
| Main Authors: | , , , , , |
|---|---|
| Format: | Conference item |
| Published: |
American Thoracic Society
2018
|